Boca BioSpecimen360 is here, a simpler way to source biospecimens.
Learn More
Cancer research today and into the future focuses on patient-specific treatments that target cancer at the cellular level. Research teams are zeroing in on solutions and finding new avenues of treatment and cancer diagnostics daily. They partner with us to develop cancer innovations from early R&D to approval faster.
Partner with our team to help you unlock the mysteries of cancer. Whether it's finding rare cancer specimens or normal healthy controls or central laboratory testing, we're your partner of choice.
Reliability and transparency delivered with a single partner
Robust global oncology clinical research site network
Custom procurement tailored to particular molecular, genetic, or study characteristics
CAP-accredited, CLIA-certified reference lab
Comprehensive menu of customizable tests, from microDNA profiling, histological servicing, and next-generation sequencing
We can help you increase the speed of your innovation. Let’s drive it with data. Let’s drive it together.
Identify genetic mutations and biomarkers relevant to various cancers utilizing techniques such as PCR, NGS, and FISH.
Identify and develop new immunotherapeutic agents, such as checkpoint inhibitors, antibody-drug conjugates, and cell therapies.
Evaluate specific proteins or genes released by tumor cells, aiding in diagnosis, monitoring treatment response, and detecting recurrence.
Delve into tumor genetics and treatment efficacy by detecting circulating tumor DNA (ctDNA), cell-free DNA (cfDNA), and circulating tumor cells (CTCs) in biofluids.
We support CDx and theranostics R&D and clinical research for a growing list of cancer types including:
Lung Cancer (SCLC and NSCLC)
Colorectal Cancer
Breast Cancer, Endometrial Cancer, Uterine Cancer
Ovarian Cancer, Cervical Cancer, Penile Cancer, Prostate Cancer
Hepatocellular Carcinoma, Kidney Cancer, Cholangiocarcinoma
Thyroid Cancer, Larynx Cancer, Gastroesophageal Junction
Melanoma, Bone Cancer, Lymph Node Cancer
Bladder Cancer, Urothelial Cancer
Abdominal Cancer. Colorectal Cancer, Colon Cancer, Stomach Cancer, Gastric Cancer, Intestine Cancer
Head and Neck Cancer, Lip Cancer, Brain Cancer, Salivary Gland Cancer
Gallbladder Cancer
And more…
Secure management of millions of data points with our LIMS
Rigorous QC to meet the highest standards
Data reporting with clear, consistent, and customizable formats
Thorough data handling and storage practices built for security
Serum
Plasma
FFPE blocks
Fresh frozen tissue
Tumor curls
Buffy Coat
PBMCs
Custom patient-matched sets
Prospective longitudinal sets
Retrospective and prospective collections
WES
WGS
Transcriptome sequencing
RNA-Seq
Proteomic analyses
IHC
Liquid biopsy
Urinalysis
Tumor markers
Blood chemistries
Quality control
*Tumor markers testing is conducted in-house at our CLIA-certified and CAP-accredited Boca Bio Reference Laboratory. Tests not performed on-site are managed through our trusted partner labs.
Biomerieux BioFire® FilmArray®
Roche Cobas® 4800 x
Roche Cobas® 4800 z
BD MAX™ System
Hologic Panther® System
Hologic Panther Fusion®
Cepheid GeneXpert®
Bio-Rad CFX96 Touch™
ThermoFisher QuantStudio™ 5
ThermoFisher QuantStudio™ 6 Pro
PerkinElmer Chemagic™ 360
DiaSorin LIAISON® MDX
Abbot CELL-DYN Emerald
Abbott Architect i100
Abbott Architect c4000
DiaSorin LIAISON® XL
Bio-Rad Geenius™ Reader
Roche Cobas® e411
We partner with your scientists who are passionate about developing solutions that improve patients' lives. With Boca Bio, your team gets the necessary cancer specimens, services, and data to develop therapies, companion diagnostics, biologics, and novel cell and gene therapies. Let us support the development of your next precision oncology breakthrough.
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Diasorin Liaison XL
Boca Bio provides oncology specimens including serum, plasma, FFPE tissue, fresh-frozen tissue, tumor curls, buffy coat, PBMCs, matched sets, and prospective longitudinal collections across multiple cancer types.
Yes. Boca Bio can evaluate custom procurement based on cancer type, stage, histology, treatment status, molecular profile, biomarker status, demographics, specimen format, and required clinical annotations.
Boca Bio combines oncology biospecimens, custom patient cohorts, prospective collections, laboratory testing, biomarker analysis, clinical research services, data management, and biostorage to support companion diagnostic and precision-oncology programs.
Tumor-marker testing is performed in Boca Bio’s CAP-accredited and CLIA-certified laboratory. Testing not performed on-site may be coordinated through qualified partner laboratories, depending on the project.
